| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/25/2013 | WO2013107428A1 7-substituted hanfangichin b derivative, and preparation method and use thereof |
| 07/25/2013 | WO2013107405A1 Therapeutically active compounds and their methods of use |
| 07/25/2013 | WO2013107326A1 NEW-TYPE IMIDAZO [1, 2-a] PYRIDINE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF |
| 07/25/2013 | WO2013107291A1 Therapeutically active compounds and their methods of use |
| 07/25/2013 | WO2013107285A1 Amino heteroaryl compound, preparation method therefor and use thereof |
| 07/25/2013 | WO2013107283A1 Benzoheterocyclic compounds and use thereof |
| 07/25/2013 | WO2013107278A1 New-type anti-cancer compounds synthesized from reaction of ketone and indole derivatives |
| 07/25/2013 | WO2013107225A1 N-((4-chloro-3-trifluoromethyl)phenyl)-n'-(2-fluoro-4-((2-hydroxymethylaminoformyl)-4-pyridyloxo)phenyl)urea and use thereof as anti-cancer drug |
| 07/25/2013 | WO2013107189A1 Gambogenic acid derivatives, preparation method and application thereof |
| 07/25/2013 | WO2013107164A1 Novel indoleamine-2, 3-dioxygenase inhibitor, preparation method therefor and uses thereof |
| 07/25/2013 | WO2013106913A1 Biomarkers for breast cancer prognosis and treatment |
| 07/25/2013 | WO2013080217A3 Crystalline forms of carbazitaxel and process for preparation thereof |
| 07/25/2013 | WO2013071016A3 Methods of inhibiting tumor growth by antagonizing il-6 receptor |
| 07/25/2013 | WO2013070988A3 Method of treating osteosarcoma |
| 07/25/2013 | WO2013042124A8 Use of strigolactones and strigolactone analogs for treating proliferative conditions |
| 07/25/2013 | WO2013040227A3 Therapeutic compounds |
| 07/25/2013 | WO2013030778A3 Organic compositions to treat hsf1-related diseases |
| 07/25/2013 | WO2013016531A3 Compounds and methods for use in treating neoplasia and cancer |
| 07/25/2013 | WO2012167944A8 Modulators of adp-dependent glucokinase (adpgk) and glycerol-3-phosphate dehydrogenase (gpd2) for therapy |
| 07/25/2013 | WO2012022677A3 Combination therapy for the treatment of cancer |
| 07/25/2013 | US20130190495 Compositions and methods of treatment of cancer |
| 07/25/2013 | US20130190450 Cyclodextrin-based polymers for therapeutics delivery |
| 07/25/2013 | US20130190350 Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto |
| 07/25/2013 | US20130190250 Polynucleotides Encoding Human Signal Peptide-Containing Proteins |
| 07/25/2013 | US20130190247 Peptide antagonists of zonulin and methods for use of the same |
| 07/25/2013 | US20130189356 Pellet formulation for the treatment of the intestinal tract |
| 07/25/2013 | US20130189338 Bone fibers having extended length |
| 07/25/2013 | US20130189240 Composition containing pias3 as an active ingredient for preventing or treating cancer or immune disease |
| 07/25/2013 | US20130189219 N-terminally chemically modified protein compositions and methods |
| 07/25/2013 | CA2861367A1 Chitosan-derived compositions |
| 07/25/2013 | CA2861339A1 Metalloenzyme inhibitor compounds |
| 07/25/2013 | CA2857346A1 1,5-naphthyridine derivatives and melk inhibitors containing the same |
| 07/25/2013 | CA2854093A1 3,5-disubstituted alkynylbenzene compound and salt thereof |
| 07/24/2013 | EP2617737A1 High purity heparin and production method therefor |
| 07/24/2013 | EP2617736A1 Anti-glypican 3 antibody having improved kinetics in plasma |
| 07/24/2013 | EP2617720A1 Novel cortistatin a analog and use thereof |
| 07/24/2013 | EP2617719A1 Maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| 07/24/2013 | EP2617426A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method |
| 07/24/2013 | EP2617422A1 Anti-tumor activity of reduced folates like methylene-tetrahydrofolate, tetrahydrofolate or methyl-tetrahydrofolate |
| 07/24/2013 | EP2617421A1 Tetrahydrofolates in combination with EGFR-inhibitors in the use of treating cancer |
| 07/24/2013 | EP2617419A1 Aza spiro alkane derivatives as inhibitors of metallproteases |
| 07/24/2013 | EP2617416A1 Cancer heat therapy-enhancing agent |
| 07/24/2013 | EP2617414A2 Smoothened antagonism for the treatment of hedgehog pathway-related disorders |
| 07/24/2013 | EP2617413A2 Nano-vehicle derived from tumor tissue, and cancer vaccine using same |
| 07/24/2013 | EP2616468A1 Fused heteroaryls and their uses |
| 07/24/2013 | EP2616467A1 Substituted azaindoles |
| 07/24/2013 | EP2616456A1 Nuclear export inhibitors |
| 07/24/2013 | EP2616445A2 Estrogen receptor modulators and uses thereof |
| 07/24/2013 | EP2616443A1 Phtalazine derivatives as jak1 inhibitors |
| 07/24/2013 | EP2616442A1 Inhibitors of pi3k-delta and methods of their use and manufacture |
| 07/24/2013 | EP2616086A1 Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof |
| 07/24/2013 | EP2616063A1 Hsp90 inhibitors for treating non-small cell lung cancers in wild-type egfr and/or kras patients |
| 07/24/2013 | EP2616057A2 Combination of braf and vegf inhibitors |
| 07/24/2013 | EP2616054A2 Therapy for mll-rearranged leukemia |
| 07/24/2013 | EP2616051A1 Pharmaceutical and/or dietary compositions based on short chain fatty acids |
| 07/24/2013 | EP2615918A1 Fatty acid synthase inhibitors |
| 07/24/2013 | CN1989122B Novel cylopenta[b]benzofuran derivatives and the utilization thereof |
| 07/24/2013 | CN1863800B Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/24/2013 | CN1853730B Modified cytokines for use in cancer therapy |
| 07/24/2013 | CN1705740B Adenovirus expressing genes in reverse order and use thereof |
| 07/24/2013 | CN103221428A 4-1BB binding molecules |
| 07/24/2013 | CN103221427A Anti-OX40 antibodies and methods of using the same |
| 07/24/2013 | CN103221415A Oxazolo [5, 4 -] pyridin-5-yl compounds and their use for the treatment of cancer |
| 07/24/2013 | CN103221388A Novel sulfonamide compounds for inhibition of metastatic tumor growth |
| 07/24/2013 | CN103221386A Matrix metalloproteinase inhibitors |
| 07/24/2013 | CN103221373A Methods and compositions for treating lung cancer |
| 07/24/2013 | CN103221094A Crystalline form of an inhibitor of MDM2/4 and P53 interaction |
| 07/24/2013 | CN103221069A Alumina nanoparticle bioconjugates and methods of stimulating an immune response using said bioconjugates |
| 07/24/2013 | CN103221066A Sustained-release pharmaceutical composition |
| 07/24/2013 | CN103221060A Tumor growth controlling method targeting galactosylceramide expression factor-1 |
| 07/24/2013 | CN103221054A Novel polymer derivative of cytidine metabolism antagonist |
| 07/24/2013 | CN103221050A Combination of bevacizumab and 2,2-dimethyl-N-((S)-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-N'-(2,2,3,3,3-pentafluoro-propyl)-malonamide for the treatment of proliferative disorders |
| 07/24/2013 | CN103221044A Xanthanodien for the treatment of cancer |
| 07/24/2013 | CN103221042A Methods of treating bladder cancer |
| 07/24/2013 | CN103221040A Disulfiram formulation and uses thereof |
| 07/24/2013 | CN103221039A Airway administration of angiogenesis inhibitors |
| 07/24/2013 | CN103221034A Nano-vehicle derived from tumor tissue, and cancer vaccine using same |
| 07/24/2013 | CN103217534A Lung cancer marker SBP-1 and its application |
| 07/24/2013 | CN103215351A In vitro cancer therapy compound identification method |
| 07/24/2013 | CN103215273A Protein CGREF1 inhibiting cell proliferation, and expression sequence and application thereof |
| 07/24/2013 | CN103215270A DNA (deoxyribonucleic acid) segment with function of inhibiting cell migration and invasion of glioma, and application of DNA segment |
| 07/24/2013 | CN103215268A Human fascin-1 gene siRNA and applications thereof |
| 07/24/2013 | CN103215257A Protein for treating hemangioma |
| 07/24/2013 | CN103215256A Polynucleotide having tumor cell inhibition function |
| 07/24/2013 | CN103215216A Melanoma therapeutic plasmid DNA (deoxyribonucleic acid) vaccine pSVK-CAVA preparation method as well as dedicated engineering bacterium and fermentation culture medium thereof |
| 07/24/2013 | CN103214635A pH sensitive super-hydrophobic triblock copolymer as well as preparation method and application thereof |
| 07/24/2013 | CN103214584A Fusion protein with double functions of inhibiting revascularization of tumor microenvironment and activating adaptive immune response, and gene and application thereof |
| 07/24/2013 | CN103214580A Anti Her2 immune cytokine and application thereof |
| 07/24/2013 | CN103214578A Novel humanized anti-CD22 antibody |
| 07/24/2013 | CN103214562A Attenuated enterotoxin C2 superantigen mutant protein as well as preparation method and application thereof |
| 07/24/2013 | CN103214559A Micro-molecule polypeptide for killing chronic myeloid leukemia (CML) cells |
| 07/24/2013 | CN103214556A Anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide from MAT1 (Metastasis Associated Gene1) and application thereof |
| 07/24/2013 | CN103214555A Peptide inhibitors for mediating stress responses |
| 07/24/2013 | CN103214548A Synthetic method of B-drop-D-homo-lactam steroid compound with [6-5-6-6] steroid nucleus structure |
| 07/24/2013 | CN103214543A New maslinic acid derivatives, preparation method, and applications of new maslinic acid derivative in antitumor drug |
| 07/24/2013 | CN103214542A B-nor-6-(4'-alkyl) aminothizone cholestane compound, and preparation method and application thereof in anticancer drugs |
| 07/24/2013 | CN103214536A Polyhydroxy steroidal compounds separated from coral, and application thereof |
| 07/24/2013 | CN103214502A Binuclear zinc complex and preparation method and applications thereof |
| 07/24/2013 | CN103214497A Physalin A extracting process and medical application thereof |
| 07/24/2013 | CN103214495A Anti-cancer 4'-demethylation-4'-oxy-cyclobutyl formyl-deoxidation podophyllotoxin and preparation method thereof |